ISPE Vendor Night – Solaris was there!
San Francisco Bay Area, 3th March 2022
The ISPE (Internation Society for Pharmaceutical Engineering) provides valued products and services such as on-going education and training programs with the purpose to stay current on the latest industry trends on a worldwide basis. ISPE working with the FDA to develop Pharmaceutical Engineering Guides, articles, career opportunities activities and ISPE Discussion Forum Groups.
The ISPE San Francisco/ Bay Area Chapter and all its related event were founded in 1991 as a non-profit initiative.
Every year the events are joined by biotechnology, pharmaceutical and medical device manufacturers, architects/engineers, construction firms, government agencies, universities, equipment manufacturers, and suppliers.
On March 3, 2022 Solaris had the opportunity to take part in the 29th edition of the Vendor Night Exhibit Show Mask’erade Theme.
The company partecipate with a voluntary branded stand in which could show its flagship laboratory product: a Jupiter and all the Solaris production.
The San Francisco’s Oracle Park hosted suppliers from different fields of production, allowing Solaris to be present and constantly improve its participation and knowledge in the biotechnology market. For the company in fact, it is not only the awareness of what is already being done that defines the future of one’s business.
The event was in combination with the ISPE CEO Night and the participation of Tatjana Naranda, PhD and the Chief Operating Officer Alexza Pharmaceuticals made it possible to get to know the most current and innovative themes and ideas of the pharmaceutical world.
Take part to voluntary initiave, have the opportunity to show the production, the ideas, the values and the mission especially with respect to these current as well as innovative themes it is very important for Solaris.
To be aware about how the world needs you and everything you do every day is what encourages you to do better and better to help improve the reality that surrounds you.